HAMPTON, Va., March 4, 2019 – Brian Clare, M.D. chief medical officer and member of the Board of Directors at ivWatch, a medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous (IV) therapy, gained recognition as an Inside Business 2019 Health Care Hero during the publication’s annual breakfast March 4 at Norfolk Waterside Marriott. Dr. Clare was recognized as the winner in the ‘Innovations in Health Care’ category for his efforts during his long-standing medical career as an emergency medicine physician and for his work locally helping companies gain critical access to resources.
“Dr. Clare is all business when it comes to medicine,” remarked program judge Kathryn Barrett of Barrett Communications and former WVEC-TV medical editor.
The Health Care Heroes awards epitomize the spirit embodied in the word “hero” in the delivery of health care in the Hampton Roads community; Clare’s reach extends far beyond. Notable achievements include creating one of the first Scribe companies in the United States helping physicians with documentation overburden, and helping secure regulatory clearance for the ivWatch Model 400, a medical device that offers hospitals and health care facilities a means to protect patients from a common complication of IV therapy.
“Brian has been very entrepreneurial in medicine and on the leading edge of developing new markets to correct health care inefficiencies,” said Gary Warren, president and CEO of ivWatch. “Brian’s guidance has been instrumental in helping us secure many of our most important milestones.”
In addition to his advisory roles at ivWatch and other organizations based in Hampton Roads, Clare leads the board of Richmond-based non-profit World Pediatric Project as Chairman, providing life-saving care for critically ill children in the Caribbean and Central America.
To learn more about ivWatch and their leadership team, visit https://www.ivwatch.com/about-us/.
ivWatch, LLC is a medical biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is pioneering the use of optical sensors to detect adverse IV events early to minimize the risk of injury caused by infiltrations and extravasations. By using this technology, clinicians are able to leverage continuous monitoring to help identify infiltrations as early as possible. Our innovative monitored IV solutions are backed by decades of clinical research and device development. To learn more, follow us on Twitter @ivWatch or Facebook @ivWatchLLC, or visit www.ivwatch.com.
ivWatch is pleased to sponsor the work of myIV.com, an online resource dedicated to empowering visitors with information on all things IV, simplified.
Mobile (757) 633-4688